Altamira Therapeutics Ltd CYTO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/14/24 EDT
1.44UNCH (UNCH)
Volume
38,860
52 week range
1.35 - 23.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.44
  • 52 Week High23.60
  • 52 Week High Date05/24/23
  • 52 Week Low1.35
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap3.226M
  • Shares Out2.24M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.43
  • YTD % Change-58.62

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.44
  • 52 Week High23.60
  • 52 Week High Date05/24/23
  • 52 Week Low1.35
  • 52 Week Low Date04/25/24
  • Market Cap3.226M
  • Shares Out2.24M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.43
  • YTD % Change-58.62

RATIOS/PROFITABILITY

  • EPS (TTM)-17.59
  • P/E (TTM)-0.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-6.383M
  • ROE (TTM)-1,123.74%
  • Revenue (TTM)-
  • Gross Margin (TTM)-87.90%
  • Net Margin (TTM)-8,680.19%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Altamira Therapeutics Ltd

 

Profile

MORE
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and...
Address
Clarendon House, 2 Church Street
Hamilton, ZUG
6300
Bermuda

Top Peers

SYMBOLLASTCHG%CHG
BCEL
Atreca Inc
0.095UNCHUNCH
THAR
Tharimmune Inc
0.3646-0.0064-1.7251%
NDRA
ENDRA Life Sciences Inc
0.2897-0.0014-0.4809%
PHIO
Phio Pharmaceuticals Corp
0.7338+0.0416+6.0098%
PBLA
Panbela Therapeutics Inc
0.4407UNCHUNCH